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We can easily be left behind by the
explosion in technological developments
in medicine—or is it just a sign of getting
older? Many of us will remember a time
before MRI were readily available, and
having to learn what fat suppressed
images, T1s and T2s actually meant.
Genomics is another example of a
rapidly expanding technological develop-
ment with major implications for medi-
cine, and even experienced clinicians
(many without formal training in molecu-
lar biology) are struggling to understand
this. It requires learning a whole new lan-
guage. The sequencing of the 3.2 billion
nucleotides that compose the human
genome was ﬁrst completed only in 2003,
at an estimated cost of $2.7 billion. At the
time, it was simply something of interest,
unlikely to inﬂuence our working lives
any time soon. Now, in just over a decade,
it is possible to sequence the whole
genome for $1000.
GENOMICS LITERACY—WHAT DOES
IT ALL MEAN?
Genomics is ﬁnding its place in medicine,
from genetic testing for rare disorders to
personalised medicine based on our
genetic make up (see page 1517).
However, the role of most of the genes in
the human genome is still unknown.
A ‘snip’ is no longer just a glib term for
vasectomy, because in genomics, an SNP
(pronounced ‘snip’) is a ‘single nucleotide
polymorphism’. SNPs are locations within
the human genome where the type of
nucleotide present can differ between
individuals. You also need to know
Genome-wide Association Studies
(GWAS) from candidate gene study in the
new world of ‘Omics’. Candidate gene
studies test the validity of an ‘educated
guess’ of one or more variants within the
candidate gene in relation to a particular
condition, for example, Achilles
tendinopathy and the COL1A1 gene,
which encodes for the α1(I) chain of type
I collagen (see page 1497). They were pre-
dominantly used before testing of the
whole genome became easily available.
GWAS examine SNPs across the genome,
looking for associations with particular
conditions. Scanning the whole genome is
a broad ﬁshing expedition approach
without any prior assumptions.
‘Omics’ technologies (ﬁgure 1) are
aimed at the universal detection of genes
(genomics), messenger RNA (mRNA)
(transcriptomics), proteins (proteomics)
and metabolites (metabolomics), with the
contention that a complex system can be
more easily understood if considered as a
whole. Claude Bouchard reﬂects on the
complexity of exercise genomics and how
little we really know. The research to date
has failed to adequately deliver results,
but Bouchard shares a clear alternative
view for future research.
THE ‘SCIENCEPLOITATION’ OF
DIRECT-TO-CONSUMER GENETIC
TESTING FOR TALENT ID
We need to be able to critically review
information—another important reason for
sport and exercise medicine to get to grips
with the new world of ‘Omics’. Sequencing
or genotyping is much cheaper now and
therefore readily available, but the inter-
pretation of results is still at an early stage.
It is, in fact, open to what has been termed
‘scienceploitation’.
Researchers can be blamed for overem-
phasising the validity of research ﬁndings
in the game of publication pursuit, which
can be exploited for commercial purposes.
We have recently seen the emergence of
Direct-to-Consumer testing, for the
purpose of talent identiﬁcation and to
assess potential for future sports perform-
ance, being sold to the unsuspecting
public. ‘Pay $100–$200 and we will tell if
you have a future champion on your
hands’. There are nearly 40 companies,
worldwide, offering analyses of saliva or
buccal smear samples without counselling
or consideration of the validity of the
results or the impact of the report. Many
will then offer the opportunity to buy
their supplements to enhance training.
The consensus agreement (from the
researchers who performed the studies
Figure 1 The ‘Omics’ cascade—from gene to metabolism (from Pitsiladis, et al1).
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that these companies quote), is that, at
present, DNA testing has no role. SEM
physicians need to discourage any parent,
child or coach from using these tests (see
page 1486).
FROM THE LABORATORY TO THE
CLINIC—WHAT ROLE FOR
GENOMICS?
What is the role of ‘Omics’ in sport? How
do we keep up with the essentials? We are
practising in the age of personalised SEM;
personal whole genome sequencing, per-
sonal health records and personal techno-
logical health applications (smart phones,
etc). The world is getting smaller. This is
good for partnerships forcing us to com-
municate and collaborate—with each
other, with the research community and
with patients.
There clearly needs to be a willingness to
collaborate—to advance not only the
science but also the translation to concrete
guidelines for clinical SEM practice. New
initiatives are required to address these deﬁ-
ciencies in our knowledge, and to develop
practical and valid guidance for SEM.
Professor Claude Bouchard highlights the
danger of performing sports genetics
research with limited subject numbers (see
page 1492).
Large collaborative studies with appropri-
ately phenotyped subjects, incorporating
genome-wide approaches may be able to
deliver some answers. In time, we may
understand how to use this information to
safely guide athletes. What is clear is that
SEM practitioners in the 21st century need
to engage in the genetics of sport, exercise
and injury—now.
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Deﬁnitions
Genome: The total DNA of a cell or organism
Polymorphism: Variations in DNA at a speciﬁc site
Transcriptomics: The study of the mRNA within a cell or organism
Transcriptome: The total mRNA in a cell or organism
Proteomics: The large-scale study of proteins, including their structure and
function, within a cell/system/organism.
Proteome: The set of all expressed proteins in a cell, tissue or organism
Metabolomics: The study of global metabolite proﬁles in a system (cell, tissue
or organism) under a given set of conditions
Metabolome: The total quantitative collection of low-molecular-weight
compounds (metabolites) present in a cell or organism that participates in metabolic
reactions.
Genome Wide Association Studies: Their purpose is to determine alleles that correlate to
different diseases and traits with a hypothesis free approach.
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